drugset / Trial / NCT04727580
HSK7653 in Chinese Patients with Impaired Glucose Tolerance
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being done to evaluate the efficacy, safety of HSK7653 in chinese participants with impaired glucose tolerance.
Timeline
- Start
- 2021-03-29
- Primary completion
- 2022-06-12
- Completion
- 2022-06-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK7653 | Unknown | 10 mg | Oral |
| Subject | HSK7653 | Unknown | 25 mg | Oral |